Maysa Falah

Academic profile

Dr Maysa Falah

Lecturer in Biomedical Sciences
Peninsula Medical School (Faculty of Health)

Overview

Fingerprint

Network

Research outputs

Similar profiles

About Maysa

 

I hold a doctorate in Pharmacology (DPhil) from the University of Oxford, complemented by further specialization in Epidemiology and Public Health from Imperial College London. My academic journey includes significant contributions at the University of Oxford, where I served as a Lecturer in Medicine at Harris Manchester College, University of Oxford, teaching Pharmacology, Physiology, and Pathology to Graduate Entry Medicine students while conducting postdoctoral research on neurodegenerative and metabolic disorders. This research was part of a collaborative project between the University of Oxford (Professor Frances Platt’s Lab) and Orphazyme, a biopharmaceutical company specializing in rare diseases, based in Copenhagen, Denmark. This dual role combined academic research and industry engagement, focusing on the therapeutic potential of proteostasis modulators in lysosomal storage disorders. These experiences have shaped a research and teaching profile committed to translational science, medical curriculum innovation, and the advancement of global health education.

Education & Teaching

Pathology Lead, BMBS Programme

  • Ensure the discipline remains contemporary and meets recommended national subject guidelines, GMC requirements, and the educational values of the Medical School.

  • Actively contribute to the discipline’s development and delivery within the BMBS programme.

  • Deliver Pathology Plenaries for the BMBS programme.

Lead for Team-Based Learning for Foundation Year Programme (Faculty of Health)
Programmes:

  • Bachelor of Dental Surgery with Integrated Foundation Year

  • Bachelor of Medicine, Bachelor of Surgery with Foundation Year (Year 0)

  • BSc (Hons) Biomedical Science with Integrated Foundation Year

  • BSc (Hons) Dental Therapy and Hygiene with Integrated Foundation Year

  • BSc (Hons) Dietetics with Integrated Foundation Year

  • BSc (Hons) Diagnostic Radiography with Integrated Foundation Year

  • BSc (Hons) Nursing (Adult Health) with Integrated Foundation Year

  • BSc (Hons) Nursing (Child Health) with Integrated Foundation Year

  • BSc (Hons) Nursing (Mental Health) with Integrated Foundation Year

  • BSc (Hons) Occupational Therapy with Integrated Foundation Year

  • BSc (Hons) Paramedic Science with Integrated Foundation Year

  • BSc (Hons) Physiotherapy with Integrated Foundation Year

  • BSc (Hons) Podiatry with Integrated Foundation Year

  • MOptom (Hons) Optometry with Integrated Foundation Year

  • University of Bath MPharm students

  • Contribute to the development and design of this programme.

  • Create programme overviews, syllabi, handbooks, and assessment assignments and criteria.

  • Responsible for the overall delivery, planning, induction, and evaluation.

LSRC BMBS Sessions Provider

Plenary / Pathology, Year 2 BMBS

Evidence-Based Learning Facilitator for Year 1 (BMBS)

Student Selective Component Facilitator for Year 1 & 2 (BMBS)

Personal Academic Tutor (Years 0, 1, 2), BMBS

MSc Supervisor – Global Health / Clinical Education

  • Teaching and dissertation supervision of M.Sc. students.

M.Sc. Students Supervised (Primary Supervisor):

  • Dr Rehab Osman – Evaluation of Efficacy and Safety of Semaglutide in Management of Obesity and Overweight: A Scoping Review (2022–2023)

  • Dr Eman Mohammedi – The Effect of Essential Oils in Improving Skin Conditions: A Systematic Review (2021–2022)

  • Dr Kat Gangly – A Focused Study Evaluating the Stability of a Selection of Drugs Used by the British Antarctic Survey Medical Unit (2021–2022)

Research

Pharmacoepidemiology Research Group
My research aims to enhance understanding of the epidemiology and impact of poor-quality medicines, contributing to medicine quality surveillance, public health interventions, and healthcare systems through interdisciplinary research.

Key objectives include:

  • Investigating the prevalence, education, and awareness of low-quality medicines in LMICs

  • Conducting prevalence studies on medicine quality, particularly antibiotics

  • Assessing low-quality medicines in disaster-affected areas, including:

    • Examining antimicrobial resistance (AMR) in disaster-impacted regions

    • Adapting Guidelines for Field Surveys of the Quality of Medicines for disaster settings

Neuropharmacology Research Group
My research investigates the pathology of neurodegeneration and the development of novel pharmacological therapies aimed at mitigating its progression. A major focus is on lysosomal storage disorders, where I study how proteostasis modulators can restore lysosomal function and cellular homeostasis. I have also explored the molecular mechanisms underlying hippocampal sclerosis, particularly the role of the cyclin-dependent kinase 5 (Cdk5) pathway and NMDA receptor signaling in neurodegenerative processes linked to pharmacoresistant epilepsy.

 

Contact Maysa